Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Inflammation is a common factor of chronic periodontitis and diabetes. However, to date, there is no scientific evidence supporting a causal effect of the inflammation created by apical periodontitis on the onset of insulin resistance and on metabolic derangement in the condition of pre-diabetes or diabetes.
A case control study has been designed in order to evaluate serum levels of pro-diabetes inflammation factors in a sample of healthy patients between 25 and 55 years of age, with or without apical periodontitis,before endodontic treatment and at 6 and 12 months post-treatment. The aim of the study is to evaluate any relation between the presence of chronic endodontic lesions and pro-diabetes inflammation factors that can promote the onset of insulin resistance, and whether endodontic treatment can reduce these factors, thus preventing a pro-diabetes status.
Healthy, consenting and informed patients of both gender under 55 years of age with apical periodontitis will be enrolled as cases. Healthy, consenting and informed patients of both gender under 55 years of age without apical periodontitis will be enrolled as control subjects. The study has been designed to assess the serum level of TNF-α, IL-1β, IL-6, IL-8 by ELISA assay.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| AP group | Healthy patients between 25-55 years with Apical Periodontitis | ||
| Control Group | Healthy patients between 25-55 years without Apical Periodontitis |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Variation in pro-diabetes inflammation markers over time upon endodontic intervention. | Dosage of TNF-α, IL-1β, IL-6, IL-8 (pg/mL) in serum(ng/10^6 platelets) by ELISA assay. | Baseline serum levels of selected pro-diabetes inflammation markers in control group and AP group. |
| Variation in pro-diabetes inflammation markers over time upon endodontic intervention. | Dosage of TNF-α, IL-1β, IL-6, IL-8 (pg/mL) in serum by ELISA assay. | Serum levels of selected pro-diabetes inflammation markers at 6 months after endodontic treatment and in control group. |
| Variation in pro-diabetes inflammation markers over time upon endodontic intervention. | Dosage of TNF-α, IL-1β, IL-6, IL-8 (pg/mL) in serum by ELISA assay. | Serum levels of selected pro-diabetes inflammation markers at 12 months after endodontic treatment and in control group. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Dental Hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Damiano Pasqualini, DDS Ass Pro | Endodontics, Department of Surgical Sciences - Univeristy of Turin | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Oncology - University of Turin | Turin | 10126 | Italy | |||
| Endodontics, Department of Surgical Sciences - Univeristy of Turin |
Not provided
| ID | Term |
|---|---|
| D010485 | Periapical Periodontitis |
| D007333 | Insulin Resistance |
| D011236 | Prediabetic State |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D010483 | Periapical Diseases |
| D007571 | Jaw Diseases |
| D009057 | Stomatognathic Diseases |
| D010510 | Periodontal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood Sample
| Turin |
| 10126 |
| Italy |
| D009059 |
| Mouth Diseases |
| D010518 | Periodontitis |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |